Infectious diseases - DONE Flashcards
Measles - etiology:
Morbillivirus
Measles - Period of incubation:
9-11 days
Measles - infectiousness:
3-5 days before exanthema and up to 4 days after
Measles - infectiousness:
Catharus period
- Fever
- Dry, ,,barking’’ cough
- Running nose
- Conjunctivitis and photophobia
- Koplik’s macule
Measles - eruptive period:
- Fever > 40oC (…F), sudden, simultaneously with exanthema
- Catharus symptoms are over
- Exanthema - small spots behind ears, on neck, along line’s of hair then spotty, lumpy, cast or haemorrhagic
- 1st day: face, neck, decolletage
- 2nd day: chest , backs, abdomen, upper limb, thighs
- 3rd day: feet, hands, it goes pale on face
- Lymphadenopathy
- Splenomegaly
Measles - recovery period:
- exanthema is over
- Brown skin
- Peeling
- Return to normal activity during 10-14 days
Measles - treatment:
only symptomatical, protection from light
Measles - prognosis:
- good
- worse in immunocompromised patients
Measles - possible complications:
- middle ear inflammation
- pneumonia
- laryngitis
- death
Measles - prevention:
vaccination
Rubella - Etiology:
Viral infection: Morbillivirus
Rubella - Period of incubation:
14 – 21 days
Rubella - Infectiousness:
7 days before exanthema and up to 4-5 days after
Rubella - Clinical symptoms:
- Fever
- Lymphadenopathy (suboccipital nodus: painless, hard, like a pea)
- Exanthema - little, spoty or lumpy, rosecoloured face
- Splenomegaly
Rubella - Treatment:
only symptomatical
Rubella - Prognosis:
good, worse in immunocompromised patients
Rubella - Possible complications:
- trombocytopenia
- jointivitis
Rubella - Prevention:
vaccination
Chickenpox - Viral infection:
Varicella Zoster Virus
Chickenpox - Period of incubation:
14-16 days
Chickenpox - Infectiousness:
2 days before exanthema and up to 5 days after
Chickenpox - Clinical symptoms:
- Fever
- Exanthema - scattered (hairy skin of head too!), polymorphic: macule, lump, scab
Chickenpox - Treatment:
- Only symptomatical
- sometimes Acyclovir
Chickenpox - Prognosis:
- good
- worse in immunocompromised patients